http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201713369-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_371fc4ea338b00e82d2fb3e527d9d9b6 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10 |
| filingDate | 2015-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88aab024da252215e9ced0021a827312 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2d0cdebfc584dc7bb1d6afdcdc5a313 |
| publicationDate | 2017-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201713369-A |
| titleOfInvention | Bonding method of Trastuzumab and Indium-111 |
| abstract | A method for binding Trastuzumab to Indium-111 is to use the anti-HER2 drug, Trastuzumab monoclonal antibody specifically binds to the HER2 protein on the surface of cancer cells, and can provide a radioisotope signature, which is achieved by bonding indium-111. Effectively used in nuclear medicine imaging diagnosis and treatment of cancer to improve the ability of tumor diagnosis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I765195-B |
| priorityDate | 2015-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.